Research and Markets: Gain a Comprehensive Picture of a Company's Strategic Direction with This Latest IMS Company Profile on Boehringer Ingelheim for 2010

DUBLIN, Nov 12, 2010 (BUSINESS WIRE) -- Research and Markets (http://www.researchandmarkets.com/research/47be2d/ims_company_profil) has announced the addition of the "IMS Company Profiles: Boehringer Ingelheim" company profile to their offering.

IMS Company Profiles gives a clear picture of the companies strengths in terms of therapy areas and relevant marketed products as well as the future strategic direction of companies including R&D pipelines, analysts forecasts and events predicted to impact the future. Use IMS Company Profiles to: As a first step to any in-depth competitor analysis exercise Understand the influence of companies within therapy areas Evaluate the future drivers and potential constraints of companies Review independent analysts forecasts and commentaries Gain a comprehensive picture of a company's strategic direction Key Topics Covered: Corporate Structure Strategy Statement Detailed insights into the strategic direction of the company M&A Activity Regional Strategy Therapy Focus R&D Financial Review Based on the company financial reports and complemented by the comments and forecasts of independent financial analysts Net sales Net Profit Earnings per share R&D costs Sales by business sector Sales by geographic region Product Portfolio An extensive and detailed review of the company's portfolio of marketed products, providing insights into licensing, lifecycle management, competition Pharmaceutical Product by Therapeutic Areas Others categories can include (depending on the company): Nutritionals, Generics, OTC Products, Hospital Supplies, Animal Health, Fine Chemicals, Miscellaneous etc R&D Profile Information on the progress through the R&D pipeline including clinical data, analyst forecasts Tabular summary of Products in R&D Products in development by Therapeutic Areas Employee Data Short section providing employee statistics when available Licensing/Co-Marketing Agreements A series of tables providing essential information on the company's licensing and co-marketing agreements for all products of commercial significance Marketed Products General Research Collaborations Major Events For more information visit http://www.researchandmarkets.com/research/47be2d/ims_company_profil Source: IMS Health SOURCE: Research and Markets CONTACT: Research and Markets Laura Wood, Senior Manager, press@researchandmarkets.com U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Copyright Business Wire 2010 -0- KEYWORD: Germany



More From Press Releases